SORT BY Relevancy
In Clinical Air Episode #12, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer talks with Marc Sluijs, Director Life Science Business Development at Oracle Health Sciences.
Marc shares his thoughts on the digital health space and where technology is heading in clinical trials. In this informal discussion, Craig and Marc also cover how digital technologies can better serve patients as well as tips on keeping tabs on this rapidly moving space and what can disrupt pharma?
Head of Clinical Innovation, R&D
Director Life Science Business Development
Oracle Health Sciences
The Conference Forum
In Clinical Air episode # 8, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer hosts a show discussing investigators as partners in clinical research. Guests include:
Christine Pierre, President, Society of Clinical Research
Jacalyn Kent, Director, Clinical Development Information & Optimization, Eli Lilly
Key topics include:
Misunderstandings around Remote Based Monitoring
Training and communication challenges for remote site managers
What are the real cost savings around RBM...are we just shifting costs?
Real time data and how this should affect sites and payments
Reducing burdens to the sites
Investigator turn over rate, making sites sustainable
Join host, Craig Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on Investing in the future of clinical research.
Todd Pietri, Co-Founder, Milestone Ventures
Jeremy Sohn, Managing Director, MPM Capital
VC views on:
Disruption in the clinical trial space
Finding opportunities (incubators and accelerators)
Good sources of deal flows
Investing in technology or people?
Beyond the pill
Craig, Todd and Jeremy will also be speaking at Mobile@Dpharm on September 10th at the Farimont Copley Plaza hotel in Boston. This event helps drug developers get their arms around the mobile/digital clinical trial landscape and figure out:
How mobile is innovating clinical trials
What parts of clinical trials mobile/digital technology is currently impacting
How mobile technology is making clinical trials cheaper, easier and more accurate
How mobile/digital is increasing the efficacy of drugs
What the true value is to clinical trials
There is an opportunity to participate in creating a clinical trial app. Mobile@Dpharm will also be of interest to investors and app developers. Following this one day event is DPharm: Disruptive Innovations to Advance Clinical Trials. For more information, visit www.theconferenceforum.org or call 646 350 2580.
Design Thinking is a human centered approach to innovation that helps uncover the sweet spot of opportunity where the needs of people, the possibilities of technology and the requirements for business success all converge. The application of the Design Thinking methodology (originating out of Stanford’s d.School) as a new approach to looking at solutions can lead to disruptive innovation in clinical trials for drug development. It allows for designing new ways of working, including the needs, challenges and insights about the complex world we work in.
In this discussion, we introduce the basic principals of Design Thinking and an understanding of how the methodology teaches empathy for the end user (the patients). We explore its ability to reframe questions and unleash innovative thinking as well as the "downside" of creative tension. Most importantly, we address how Design Thinking can drive more successful trials.
Hosted by Valerie Bowling, Executive Director of the Conference Forum, guests include:
Co-Founder, The Helber Group
Co-Founder, The Helber Group
Strategic Innovation Leader, Genentech/Roche
Kate, Jen and Komathi will also be leading a hands-on program, May 11-12 in Boston. For more information, click here.
This episode provides a recap on what's happening with mobile/sensors in clinical trials especially as they affect patients.
Craig Lipset, Head of Clinical Innovation, R&D, Pfizer, Inc.
Tim Davis, CEO & Co-Founder, Exco InTouch
Abbe Steel, Vice President of Patient & Physician Services, UBC
This radio show will discuss all of the research conducted with the fire service by the UL Firefighter Safety Research Institute. Guests from fire departments that have served on the technical panels of the research will share their perspectives and how they have incorporated the results into their departments.
Host Steve Kerber is the Director of the UL Firefighter Safety Research Institute. He has led fire service research and education in the areas of ventilation, structural collapse, and fire dynamics. A 13-year veteran of the fire service, with most of his service at the College Park Fire Department in Prince George's County Maryland where he served at ranks up through Deputy Chief. He currently serves on the Advisory Board of Fire Engineering and the Fire Department Instructors Conference. Steve has also been appointed to the rank of Honorary Battalion Chief by the FDNY.
Are you ready to live your best life ever? Britt is here to help! Join her on Saturday, May 9 at 10 a.m. Eastern when she welcomes Clinical Hypnotist Janet Desaulniers:
Janet Desaulniers, C.C.H. is a Life Coach, Clinical Hypnotist, Teacher and Energy Worker. Janet has 30 years’ experience empowering individuals, couples, groups, and businesses to reach their potential and transform their lives. Janet has led seminars in whole health expos, holistic educational centers, academia, businesses and private venues. Other seminars include the Law of Attraction, Remember Who You Are, Creating a Life You Love, Healing from Grief, 2012 & Beyond, and weight loss programs.
Visit her website at JanetDesaulniers.com.
During the live show, Britt and Janet welcome calls at (347) 945-7246.
In the hour, we explore the post diagnostic implications of whole exome sequencing as it pertains to clinical practice with some eye opening data from our two speakers Julie Cohen and Dr. Alejandro Iglesias. Julie is a Genetic Counselor at Kennedy Kreiger Institute in Baltimore Maryland, and Dr. Alejandro Iglesias has been a pediatrician and geneticist for the last 25 years.
Your national award-winning family radio talk show Let's Talk America with Host Shana Thornton will present a timely news segment on the latest in cancer research on Tuesday, May 19, 2015 at 7:30 pm EST. Leading oncologist and best-selling author Dr. Mitchell Gaynor talks exclusively to Shana about genetic testing options and cancer diagnoses. Clinical oncologist and President of Science and Medicine at Cancer Treatment Centers of America’s Eastern Regional Medical Center, Dr. Maurie Markman, joins the show to discuss precision medicine and cancer treatment. This entire show will inform, inspire, and encourage.
*Please support our national sponsors by visiting www.letstalkamericawithshanathornton.com. Thank you!
Anissa Abi-Dagham, M.D. is Director of Clinical and Imaging Research and is an expert on schizophrenia
There are three phases of schizophrenia — prodromal (or beginning), active, and residual. They tend to occur in sequence and appear in cycles throughout the course of the illness.
We will be speaking today on
How does schizophrenia begin, and what is its course, What are the symptoms of schizophrenia, What causes this illness
To particpate in a research trial please call 212 568-6850 or go to
The breaking news all over the internet is that Josh Duggar has resigned from The Family Research Council after someone dug up dirt on his life when he was a teenager. Josh admitted to molesting a few of his sisters as well as a non-family member. Josh committed these crimes when he was 14 years old and his parents turned him in and got him counseling.
We'll discuss this and the issue of judgment beginning with the house of God and other news today on Free for All Friday.